Board Meeting12 Aug 2026, 04:14 pm
Bacil Pharma Board Approves Unaudited Q1 FY27 Results
AI Summary
Bacil Pharma Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the unaudited financial results for the quarter ended June 30, 2026. The company will submit these results to the exchange and make them available on its website. The board also reviewed other business activities. The meeting commenced at 3:00 PM and concluded at 4:00 PM. The results are scheduled for publication in newspapers in due course.
Key Highlights
- Board approved unaudited financial results for Q1 FY27.
- Results pertain to the quarter ended June 30, 2026.
- Financial results to be submitted to the exchange.
- Results will be published in newspapers.
- Board meeting duration was one hour.
Price Impact
More from BACPHAR